MET and head and neck squamous cell carcinoma: Clinical studies from our institution and the German Cancer Consortium (DKTK) demonstrated that dysregulated MET expression is associated with locoregional control in HNSCC patients after postoperative, but not after primary radio(chemo)therapy [13,35,44].